Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fimmu.2026.1794418.s005IntroductionHumoral immunodeficiency is frequently observed in patients affected by chronic lymphocytic leukemia (CLL). The reasons for the compromised B-cell responses are only partly understood. We hypothesized that the normal residual B cells in CLL patients are negatively influenced in their functionality by soluble factors produced by CLL cells.MethodsWe performed functional B-cell assays to analyze the influence of serum from CLL patients or conditioned medium from CLL cells cultivated with stromal cells on B cells from healthy donors. Serum from healthy individuals or conditioned medium from normal B cells was used as controls, respectively. We stimulated the B cells in a T-cell-dependent fashion and incubated them in the respective serum or conditioned medium for 5 days. We measured plasma cell differentiation, proliferation, cell death, and B-cell activation, the latter using the markers CD80, CD86, and CD25.ResultsWe did not detect significant differences supporting the hypothesis that CLL-derived soluble factors negatively influence the proliferation, activation, or cell death levels of normal B cells from healthy individuals in in vitro coculture.DiscussionOur analysis suggests no major direct inhibitory effects of CLL-derived soluble factors on normal mature B cells. Thus, it is likely that other factors lead to the known B-cell dysfunction in CLL.
Keyword(s):
activation; CLL; functionality; Genetic Immunology; leukemia.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)